Datametrex AI Limited (DTMXF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $1.06M is the value of all shares combined. Beta 1.26: the stock has moved about 26% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerDatametrex AI Limited (DTMXF) trades at $0.0292. Datametrex AI Limited operates in the AI and technology sector, providing data analytics and health security services. Market cap: $1.06M, Sector: Technology.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for DTMXF: DTMXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DTMXF against Technology peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
DTMXF: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Datametrex AI Limited (DTMXF) Technology Profile & Competitive Position
Datametrex AI Limited provides AI-powered data analytics and health security solutions, operating primarily in Canada and South Korea. The company leverages machine learning for data collection, analysis, and presentation, serving industries through its AI and Technology, and Health Security segments. It faces competition in the rapidly evolving AI and health tech landscape.
What Is the Investment Thesis for DTMXF?
Datametrex AI Limited presents a speculative investment opportunity within the AI and health security sectors. The company's negative profit margin of -114.8% indicates it is not currently profitable. Revenue growth and market expansion, particularly in the health security segment, are key value drivers. Successful adoption of its Medi-Call app and NexaSecurity platform could drive future growth. However, the company's small market capitalization and OTC listing introduce significant risk. The investment thesis hinges on Datametrex's ability to scale its AI solutions and achieve profitability in a competitive market. Investors should closely monitor financial performance and market traction.
Based on FMP financials and quantitative analysis
DTMXF Key Highlights
Market capitalization of $1.06M indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.74 reflects current unprofitability, requiring careful monitoring of future earnings.
- Gross margin of -13.4% suggests challenges in cost management and pricing strategy.
- Beta of 1.26 indicates higher volatility compared to the market, appealing to risk-tolerant investors.
- Operations in both Canada and South Korea provide geographic diversification and exposure to different market dynamics.
Who Are DTMXF's Competitors?
DTMXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| GLE Global Engine Group Holding Limited Ordinary Shares | $0.46 | +0.15% | $10.6M | 455-pillar |
| CHOW ChowChow Cloud International Holdings Ltd. | $0.44 | -1.57% | $15.6M | 499-signal |
| CLPS CLPS Incorporation | $1.07 | +4.90% | $31.9M | 375-pillar |
| SAIH SAIHEAT Limited | $23.64 | -3.39% | $43.4M | 435-pillar |
| CTM Castellum, Inc. | $0.64 | +2.82% | $60.2M | 375-pillar |
| TTEC TTEC Holdings, Inc. | $1.27 | 0.00% | $61.8M | 535-pillar |
| CSPI CSP Inc. | $7.84 | +1.23% | $79.0M | 405-pillar |
| APPEF Appen Limited | $0.88 | 0.00% | $236M | 479-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are DTMXF's Key Strengths?
Patented AI technology provides a competitive edge.
- Diversified service offerings across AI, technology, and health security.
- Presence in both Canada and South Korea offers geographic diversification.
- Proprietary NexaSecurity platform provides specialized social media monitoring capabilities.
What Are DTMXF's Weaknesses?
Negative profit margin indicates financial instability.
- Small market capitalization increases volatility and risk.
- Reliance on COVID-19 related services may decline as the pandemic subsides.
- Limited brand recognition compared to larger competitors.
What Could Drive DTMXF Stock Higher?
Potential partnerships with healthcare providers to expand Medi-Call adoption.
- Increasing demand for AI-driven data analytics solutions in various sectors.
- Expansion of NexaSecurity platform to new industries and clients.
What Are the Key Risks for DTMXF?
Financial-distress signal — its Altman Z-Score of -26.82 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger AI and IT service providers.
- Rapid technological advancements may render existing solutions obsolete.
- Negative profit margin indicates financial instability.
- OTC listing and small market capitalization increase volatility and risk.
- Regulatory changes in the healthcare and data privacy sectors.
What Are the Growth Opportunities for DTMXF?
- Expansion of Medi-Call App: The Medi-Call health app represents a significant growth opportunity for Datametrex. As telemedicine gains wider acceptance, the company can leverage this platform to connect more patients with doctors, offering subscription-based e-health services. The global telemedicine market is projected to reach $431.82 billion by 2030, growing at a CAGR of 25.9% from 2023. Successful marketing and adoption of Medi-Call could drive recurring revenue and establish Datametrex as a key player in the digital health space.
- NexaSecurity Platform Adoption: Datametrex's NexaSecurity platform offers social media discovery and monitoring capabilities. With increasing concerns about online security and misinformation, demand for social media monitoring tools is growing. The social media analytics market is expected to reach $16.55 billion by 2030, growing at a CAGR of 17.2%. By enhancing the platform's features and targeting specific industries, Datametrex can capitalize on this trend and generate revenue through subscriptions and customized solutions.
- AI-Driven Data Analytics Services: Datametrex's core strength lies in its AI-driven data analytics capabilities. As businesses generate vast amounts of data, the need for AI-powered solutions to extract insights and improve decision-making is increasing. The global big data and analytics market is projected to reach $549.7 billion by 2028, growing at a CAGR of 13.2%. Datametrex can focus on specific sectors, such as healthcare and finance, to provide tailored data analytics services and secure long-term contracts.
- Strategic Partnerships: Forming strategic partnerships with established companies in the technology and healthcare sectors can accelerate Datametrex's growth. Collaborating with larger firms can provide access to new markets, technologies, and customer bases. For example, partnering with a major hospital network could facilitate the adoption of Medi-Call and other health security services. These partnerships can enhance Datametrex's credibility and expand its reach.
- Geographic Expansion: While Datametrex currently operates in Canada and South Korea, expanding into new geographic markets represents a significant growth opportunity. Targeting regions with high demand for AI solutions and telemedicine services can diversify revenue streams and reduce reliance on existing markets. Conducting market research and establishing local partnerships are crucial for successful geographic expansion. This could include entering the US or European markets.
What Are DTMXF's Competitive Advantages?
- Patented machine learning and artificial intelligence technology.
- Diversified service portfolio across AI, technology, and health security.
- Established presence in both Canada and South Korea.
- Proprietary NexaSecurity social media monitoring platform.
What Does DTMXF Do?
Datametrex AI Limited, headquartered in Toronto, Canada, specializes in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. The company was founded to leverage AI for diverse applications, evolving into two primary segments: AI and Technology, and Health Security. The AI and Technology segment focuses on providing big data analytics and system integration services. The Health Security segment offers COVID-19 related services, concierge medical services, and telemedicine solutions. Datametrex offers a range of products including NexaSecurity, a social media monitoring platform, and Medi-Call, a health app connecting patients with doctors for e-health services. The company also sells COVID-19 test kits. Datametrex operates primarily in Canada and South Korea, aiming to expand its AI-driven solutions across various sectors. Its competitive positioning relies on patented AI technology and a diversified service portfolio, addressing both technological and health-related needs.
What Products and Services Does DTMXF Offer?
- Collects and analyzes structured and unstructured data.
- Develops and applies machine learning and artificial intelligence solutions.
- Offers health security services, including COVID-19 related services.
- Provides concierge medical services and telemedicine solutions.
- Sells COVID-19 test kits.
- Offers NexaSecurity, a social-media discovery and monitoring platform.
- Provides Medi-Call health app, connecting patients with doctors.
How Does DTMXF Make Money?
- Provides AI and Technology solutions, generating revenue through contracts and service fees.
- Offers Health Security services, earning revenue through service fees and product sales.
- Sells subscriptions to the Medi-Call health app.
- Generates revenue from the NexaSecurity platform through subscriptions and customized solutions.
What Industry Does DTMXF Operate In?
Datametrex AI Limited operates within the rapidly evolving AI and information technology services industry. The market is characterized by increasing demand for data analytics, machine learning solutions, and telemedicine services. Competition includes established IT service providers and specialized AI firms. Datametrex's focus on both AI and health security positions it uniquely, but it faces challenges in scaling and competing with larger, better-funded players. The industry is driven by technological advancements, regulatory changes, and the increasing adoption of digital health solutions.
Who Are DTMXF's Key Customers?
- Businesses seeking AI-driven data analytics solutions.
- Healthcare providers and patients utilizing telemedicine services.
- Organizations requiring social media monitoring and security solutions.
- Government agencies needing data analysis and security services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 164 days ago
- ● No analyst coverage
- ● Reported in CAD, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 39 |
| 2026-08-26 | 39 |
| 2026-08-29 | 39 |
| 2026-09-01 | 39 |
| 2026-09-04 | 39 |
| 2026-09-07 | 39 |
| 2026-09-10 | 39 |
What changed?
The score has stayed at 39.
Over the same 18 days the stock moved +34.6%.
Datametrex AI Limited Financial Trajectory
Datametrex AI Limited (DTMXF) reported $1.7M in revenue for Q1 FY2026, a decline of 16.0% compared to the prior quarter. The company recorded a net loss of $7.2M, with diluted EPS of $-0.05. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Technology. Across the four most recent quarters, DTMXF averaged $-0.02 in diluted EPS.
Company Profile
Datametrex AI Limited operates in the Information Technology Services industry within the Technology sector. It is headquartered in Toronto, CA. The company is led by CEO Paul Haber. DTMXF has traded publicly since 2017.
How Datametrex AI Limited Is Valued
Datametrex AI Limited carries a market capitalization of $1.06M, placing it in the micro-cap category.
Key Financial Metrics
Return on assets is -40.8%, showing how much profit it generates from its asset base. A current ratio of 1.70 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
Datametrex AI Limited's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -26.82 places it in the distress zone, a signal of elevated financial risk.
DTMXF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Patented AI technology provides a competitive edge.
- Diversified service offerings across AI, technology, and health security.
- Presence in both Canada and South Korea offers geographic diversification.
- Proprietary NexaSecurity platform provides specialized social media monitoring capabilities.
Bear Case
- Negative profit margin indicates financial instability.
- Small market capitalization increases volatility and risk.
- Reliance on COVID-19 related services may decline as the pandemic subsides.
- Limited brand recognition compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2026 | $2M | -$7M | -$0.05 |
| Q4 FY2025 | $2M | -$857,681.756 | -$0.01 |
| Q3 FY2025 | $791,523.026 | -$469,968.938 | -$0.01 |
| Q2 FY2025 | $804,444.78 | -$648,385.041 | -$0.02 |
Q1 FY2026 · filed 31 Mar 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from CAD at today's rate
DTMXF Latest News
-
Datametrex Announces Director Resignation and Appointment of Director
accessnewswire.com · Sep 9, 2026
-
Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
accessnewswire.com · Sep 2, 2026
-
Datametrex Announces Annual and Special Meeting Voting Results
accessnewswire.com · Aug 31, 2026
-
Datametrex Announces Transition to Semi-Annual Financial Reporting
accessnewswire.com · Aug 26, 2026
DTMXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DTMXF.
Price Targets
Wall Street price target analysis for DTMXF.
DTMXF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for DTMXF; grades run from A+ (80-100) to F (below 30).
Latest News
Datametrex Announces Director Resignation and Appointment of Director
Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Datametrex Announces Annual and Special Meeting Voting Results
Datametrex Announces Transition to Semi-Annual Financial Reporting
Leadership: Dong Hyun Shim
CEO
Dong Hyun Shim serves as the CEO of Datametrex AI Limited, leading a team of 21 employees. His leadership is focused on guiding the company's strategic direction in the AI, technology, and health security sectors. He is responsible for overseeing the development and implementation of Datametrex's AI-driven solutions and expanding its market presence in Canada and South Korea.
Track Record: Due to limited information, specific achievements, strategic decisions, and company milestones under Dong Hyun Shim's leadership cannot be detailed. His tenure and impact on Datametrex's performance require further assessment based on available financial reports and company announcements.
DTMXF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Datametrex AI Limited may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be current in their reporting obligations. Investing in OTC Other stocks carries significant risks due to the potential for lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier is also known as the Pink Open Market.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in DTMXF.
- Low liquidity can make it difficult to buy or sell shares at desired prices.
- Higher price volatility due to the OTC listing and small market capitalization.
- Potential for fraud or manipulation due to less regulatory oversight.
- OTC Other tier status indicates the company may not meet minimum financial standards.
- Verify the company's financial reporting status and access available financial statements.
- Assess the trading volume and bid-ask spread to understand liquidity risks.
- Research the company's management team and their track record.
- Review the company's filings and disclosures on the OTC Markets website.
- Consult with a financial advisor to assess the risks and suitability of investing in DTMXF.
- Understand the company's business model and competitive landscape.
- Confirm the legitimacy of the company's operations and assets.
- Operations in Canada and South Korea suggest established business activities.
- Patented AI technology indicates innovation and intellectual property.
- Presence of a CEO and management team suggests organizational structure.
- Provision of health security services indicates engagement with regulated industries.
What Investors Ask About Datametrex AI Limited (DTMXF) — Technology
Is DTMXF a good stock?
Stock Expert AI does not rate DTMXF buy, sell or hold. Datametrex AI Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about DTMXF stock?
There is currently no available analyst coverage or consensus on DTMXF stock. Given its OTC listing and small market capitalization, the stock may not be widely followed by analysts.
What are the key factors to evaluate for DTMXF?
Evaluate DTMXF on fundamentals, analyst consensus, and risk factors. The company's negative profit margin of -114.8% indicates it is not currently profitable. Not financial advice.
How frequently does DTMXF data refresh on this page?
DTMXF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven DTMXF's recent stock price performance?
Datametrex AI Limited (DTMXF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Patented AI technology provides a competitive edge. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DTMXF overvalued or undervalued right now?
Datametrex AI Limited (DTMXF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of DTMXF?
Yes, most major brokerages offer fractional shares of Datametrex AI Limited (DTMXF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track DTMXF's earnings and financial reports?
Datametrex AI Limited (DTMXF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for DTMXF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO track record.
- Lack of analyst coverage impacts investment thesis validation.
- OTC market carries inherent risks due to limited regulation and disclosure.